REIT - Healthcare Facilities
Compare Stocks
2 / 10Stock Comparison
DHC vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
DHC vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $1.96B | $149.25B |
| Revenue (TTM) | $1.52B | $11.63B |
| Net Income (TTM) | $-320M | $1.43B |
| Gross Margin | 2.1% | 39.1% |
| Operating Margin | -2.5% | 4.4% |
| Forward P/E | — | 78.4x |
| Total Debt | $2.42B | $21.38B |
| Cash & Equiv. | $122M | $5.03B |
DHC vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Diversified Healthc… (DHC) | 100 | 226.0 | +126.0% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DHC vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DHC is the clearest fit if your priority is momentum.
- +178.4% vs WELL's +42.7%
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 223.1% 10Y total return vs DHC's -29.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs DHC's 2.8% | |
| Quality / Margins | 12.3% margin vs DHC's -21.1% | |
| Stability / Safety | Beta 0.13 vs DHC's 0.55, lower leverage | |
| Dividends | 1.3% yield, 2-year raise streak, vs DHC's 0.5% | |
| Momentum (1Y) | +178.4% vs WELL's +42.7% | |
| Efficiency (ROA) | 2.3% ROA vs DHC's -7.1%, ROIC 0.5% vs -0.7% |
DHC vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DHC vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 7.7x DHC's $1.5B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to DHC's -21.1%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $11.6B |
| EBITDAEarnings before interest/tax | $219M | $2.8B |
| Net IncomeAfter-tax profit | -$320M | $1.4B |
| Free Cash FlowCash after capex | -$43M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +2.1% | +39.1% |
| Operating MarginEBIT ÷ Revenue | -2.5% | +4.4% |
| Net MarginNet income ÷ Revenue | -21.1% | +12.3% |
| FCF MarginFCF ÷ Revenue | -2.8% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.3% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.8% | +22.5% |
Valuation Metrics
DHC leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, DHC's 19.1x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.0B | $149.2B |
| Enterprise ValueMkt cap + debt − cash | $4.3B | $165.6B |
| Trailing P/EPrice ÷ TTM EPS | -6.80x | 153.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 19.11x | 66.40x |
| Price / SalesMarket cap ÷ Revenue | 1.27x | 13.99x |
| Price / BookPrice ÷ Book value/share | 1.17x | 3.35x |
| Price / FCFMarket cap ÷ FCF | — | 52.41x |
Profitability & Efficiency
WELL leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-19 for DHC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHC's 1.45x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs DHC's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -18.8% | +3.5% |
| ROA (TTM)Return on assets | -7.1% | +2.3% |
| ROICReturn on invested capital | -0.7% | +0.5% |
| ROCEReturn on capital employed | -0.8% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 1.45x | 0.49x |
| Net DebtTotal debt minus cash | $2.3B | $16.3B |
| Cash & Equiv.Liquid assets | $122M | $5.0B |
| Total DebtShort + long-term debt | $2.4B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -0.39x | 0.26x |
Total Returns (Dividends Reinvested)
DHC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $20,987 for DHC. Over the past 12 months, DHC leads with a +178.4% total return vs WELL's +42.7%. The 3-year compound annual growth rate (CAGR) favors DHC at 111.6% vs WELL's 42.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +62.9% | +14.3% |
| 1-Year ReturnPast 12 months | +178.4% | +42.7% |
| 3-Year ReturnCumulative with dividends | +847.2% | +189.5% |
| 5-Year ReturnCumulative with dividends | +109.9% | +202.3% |
| 10-Year ReturnCumulative with dividends | -29.5% | +223.1% |
| CAGR (3Y)Annualised 3-year return | +111.6% | +42.5% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than DHC's 0.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.55x | 0.13x |
| 52-Week HighHighest price in past year | $8.41 | $219.59 |
| 52-Week LowLowest price in past year | $2.80 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +96.2% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 70.1 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 2.6M |
Analyst Outlook
Evenly matched — DHC and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates DHC as "Hold" and WELL as "Buy". Consensus price targets imply 17.4% upside for DHC (target: $10) vs 6.3% for WELL (target: $227). For income investors, WELL offers the higher dividend yield at 1.30% vs DHC's 0.50%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $9.50 | $226.50 |
| # AnalystsCovering analysts | 17 | 34 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.3% |
| Dividend StreakConsecutive years of raises | 4 | 2 |
| Dividend / ShareAnnual DPS | $0.04 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% |
WELL leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DHC leads in 2 (Valuation Metrics, Total Returns). 1 tied.
DHC vs WELL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is DHC or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 2. 8% for Diversified Healthcare Trust (DHC). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — DHC or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to +109. 9% for Diversified Healthcare Trust (DHC). Over 10 years, the gap is even starker: WELL returned +223. 1% versus DHC's -29. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — DHC or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus Diversified Healthcare Trust's 0. 55β — meaning DHC is approximately 313% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 145% for Diversified Healthcare Trust — giving it more financial flexibility in a downturn.
04Which is growing faster — DHC or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 2. 8% for Diversified Healthcare Trust (DHC). On earnings-per-share growth, the picture is similar: Diversified Healthcare Trust grew EPS 23. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — DHC or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -18. 6% for Diversified Healthcare Trust — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -2. 6% for DHC. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is DHC or WELL more undervalued right now?
Analyst consensus price targets imply the most upside for DHC: 17.
4% to $9. 50.
07Which pays a better dividend — DHC or WELL?
All stocks in this comparison pay dividends.
Welltower Inc. (WELL) offers the highest yield at 1. 3%, versus 0. 5% for Diversified Healthcare Trust (DHC).
08Is DHC or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, DHC: -29. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between DHC and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DHC is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock. WELL pays a dividend while DHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.